RAS Archives - Immuneering Corporation

Deep Cyclic Inhibition of MEK: A Transformational Approach to Durable and Safe Combinations in Ras-Mutant Cancers

Presented at the 7th Annual RAS-Targeted Drug Development Summit in Boston on September 17th, 2025.